Dynamics of humoral and cellular immune responses after homologous and heterologous SARS-CoV-2 vaccination with ChAdOx1 nCoV-19 and BNT162b2-Reference-Cited by-同舟云学术

Dynamics of humoral and cellular immune responses after homologous and heterologous SARS-CoV-2 vaccination with ChAdOx1 nCoV-19 and BNT162b2

Published:2022-11 Issue: Volume:85 Page:104294
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

Vogel Emanuel^ORCID,Kocher Katharina^ORCID,Priller Alina^ORCID,Cheng Cho-Chin^ORCID,Steininger Philipp,Liao Bo-Hung,Körber Nina^ORCID,Willmann Annika,Irrgang Pascal,Held Jürgen,Moosmann Carolin^ORCID,Schmidt Viviane^ORCID,Beileke Stephanie,Wytopil Monika,Heringer Sarah^ORCID,Bauer Tanja,Brockhoff Ronja,Jeske Samuel^ORCID,Mijocevic Hrvoje,Christa Catharina^ORCID,Salmanton-García Jon,Tinnefeld Kathrin,Bogdan Christian,Yazici Sarah,Knolle Percy,Cornely Oliver A.,Überla Klaus,Protzer Ulrike,Schober Kilian^ORCID,Tenbusch Matthias^ORCID

Funder

Bundesministerium fur Bildung und Forschung Dienststelle Bonn

Bayerische Staatsministerium für Wissenschaft Forschung und Kunst

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference59 articles.

1. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination;Greinacher;N Engl J Med,2021

2. Beschluss der STIKO zur 5. Aktualisierung der COVID-19-Impfempfehlung und die dazugehörige wissenschaftliche Begründung;Vygen-Bonnet,2021

3. Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study;Hillus;Lancet Respir Med,2021

4. Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination;Barros-Martins;Nat Med,2021

5. Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2;Tenbusch;Lancet Infect Dis,2021

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Humoral immune response against SARS-CoV-2 after adapted COVID-19 vaccine schedules in healthy adults: The IMCOVAS randomized clinical trial;Vaccine;2024-11

2. Influence of AAV vector tropism on long-term expression and Fc-γ receptor binding of an antibody targeting SARS-CoV-2;Communications Biology;2024-07-16

3. Age differentially impacts adaptive immune responses induced by adenoviral versus mRNA vaccines against COVID-19;Nature Aging;2024-06-25

4. NVX-CoV2373 induces humoral and cellular immune responses that are functionally comparable to vector and mRNA-based vaccines;Frontiers in Immunology;2024-03-18

5. Heterologous Covid-19 vaccines intervention effect on reactogenicity;Journal of the Pakistan Medical Association;2023-12-24